http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2679802-C2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_974d6408a7f448e72bfc15d5da2f18ba |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-014 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-01 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-01 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P21-00 |
| filingDate | 2014-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_673f86ac7042b990e402811ce4c470d3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0876035a1493ed59486c6b053ebafef http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9f3ae884ce510472657095ed594ffdb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2bf137d944e059781b456cc62616bb3 |
| publicationDate | 2019-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2679802-C2 |
| titleOfInvention | Active substance for treating sarcopenia |
| abstract | FIELD: medicine; pharmaceuticals. n SUBSTANCE: invention relates to the pharmaceutical industry, in particular to the use of a collagen hydrolysate for the treatment of sarcopenia. Use of collagen hydrolysate as an active ingredient for the treatment of sarcopenia, wherein the collagen hydrolysate does not contain any free amino acids added to thereto and has an average molecular weight of up to 5,000 Da. Use of collagen hydrolysate as an active substance against degenerative muscle loss and for improving muscle strength. Use of collagen hydrolysate as an active ingredient for reducing age-related muscle loss. Use of collagen hydrolysate as an active ingredient for stimulating the conversion of body fat into muscle mass. Method for the treatment of sarcopenia, which comprises repeated oral administration of collagen hydrolysate to a patient in combination with muscle exercise. n EFFECT: above-described collagen hydrolysate effectively increases muscle mass, reduces fat mass and metabolic cost. n 19 cl, 2 dwg, 1 ex |
| priorityDate | 2013-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 36.